Loading...
Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy
BACKGROUND: The purpose of this study was to investigate the prognostic significance of methylation of RAS association domain family protein 1 (RASSF1A) in the promoter region for patients with stage II and III colorectal cancer (CRC) receiving oxaliplatin-based chemotherapy. MATERIAL/METHODS: There...
Na minha lista:
| Udgivet i: | Med Sci Monit |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
International Scientific Literature, Inc.
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5697441/ https://ncbi.nlm.nih.gov/pubmed/29128865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.903927 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|